Kymera Therapeutics, Inc. Common Stock KYMR
$117.39
+2.60%
at last close
Financials (TTM)
- Revenue
- $105.00 million
- Net Income
- $-299,601,000
- Net Margin
- -285.34%
- Return on Equity
- -19.85%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 6.28
- Price / Sales
- 90.30
Over the trailing twelve months, Kymera Therapeutics, Inc. Common Stock generated revenue of $105.00 million and net income of $-299,601,000, a net margin of -285.34%.
At the last closing price of $117.39, KYMR trades at 90.30 times sales, with a market capitalization of $9.48 billion.
Key Stats
- Last Close
- $117.39
- Market Cap
- $9.48 billion
- 52-Week Range
- $36.65 – $130.05
- Average Volume
- 646K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.